Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

MLA

Loo, Sun, et al. “Pretransplant FLT3-ITD MRD Assessed by High-Sensitivity PCR-NGS Determines Posttransplant Clinical Outcome.” Blood, vol. 140, no. 22, Dec. 2022, pp. 2407–11. EBSCOhost, https://doi.org/10.1182/blood.2022016567.

APA

Loo, S., Dillon, R., Ivey, A., Anstee, N. S., Othman, J., Tiong, I. S., Potter, N., Jovanovic, J., Runglall, M., Chong, C. C., Bajel, A., Ritchie, D., Gray, K., Yeoh, Z. H., McBean, M., Gilkes, A., Thomas, I., Johnson, S., Russell, N. H., & Wei, A. H. (2022). Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome. Blood, 140(22), 2407–2411. https://doi.org/10.1182/blood.2022016567

Chicago

Loo, Sun, Richard Dillon, Adam Ivey, Natasha S. Anstee, Jad Othman, Ing Soo Tiong, Nicola Potter, et al. 2022. “Pretransplant FLT3-ITD MRD Assessed by High-Sensitivity PCR-NGS Determines Posttransplant Clinical Outcome.” Blood 140 (22): 2407–11. doi:10.1182/blood.2022016567.